Cryoport
Cryoport, Inc., a leading provider in the biopharmaceutical supply chain, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 2012, the company has established itself as a pivotal player in the temperature-controlled logistics sector, particularly for the life sciences industry. Specialising in cryogenic logistics, Cryoport offers innovative solutions for the transportation of biological materials, including cell and gene therapies. Their unique Cryoport Express® system ensures the integrity and viability of sensitive shipments, setting them apart in a competitive market. With a commitment to quality and compliance, Cryoport has achieved significant milestones, including partnerships with major pharmaceutical companies and a robust network of global facilities. This positions Cryoport as a trusted leader in the critical field of biopharmaceutical logistics.
DitchCarbon Score
How does Cryoport's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cryoport's score of 37 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cryoport's reported carbon emissions
In 2023, Cryoport, headquartered in the US, reported total carbon emissions of approximately 8,000,000 kg CO2e. This figure includes 1,605,000 kg CO2e from Scope 1 emissions, which comprise mobile combustion (1,023,000 kg CO2e), fugitive emissions (153,000 kg CO2e), and stationary combustion (429,000 kg CO2e). Additionally, Scope 2 emissions accounted for about 6,672,000 kg CO2e, while Scope 3 emissions, specifically from waste generated in operations, contributed 211,000 kg CO2e. Comparatively, in 2022, Cryoport's total emissions were around 7,000,000 kg CO2e, with Scope 1 emissions at 1,352,000 kg CO2e and Scope 2 emissions at 6,231,000 kg CO2e. The Scope 3 emissions for that year included 217,000 kg CO2e from business travel and 224,000 kg CO2e from waste generated in operations. Cryoport has not set specific reduction targets or initiatives as part of their climate commitments, nor do they participate in the Science Based Targets initiative (SBTi). Their emissions data is not cascaded from any parent organisation, indicating that these figures are independently reported by Cryoport, Inc. Overall, Cryoport's emissions reflect their operational impact, and while they have not established formal reduction targets, their commitment to transparency in reporting emissions is evident.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 2,613,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 6,988,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 142,000 | 000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cryoport is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
